Johnson & Johnson (JNJ)

Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: United States
Exchange: NYSE
Market cap: $643.09B
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Latest financial period: September 27, 2026
Filed with the SEC: October 21, 2026
Estimated earnings date: Not available
Profit #359 of 1422 companies
| | Sep 26 | Jun 26 | Mar 26 | Dec 25 |
|---|
| ROE/ROA | 75.2% | 80.1% | 80.5% | 83.6% |
Growth #870 of 1422 companies
Payout #207 of 1422 companies
Safety #499 of 1422 companies
Price #1059 of 1422 companies